Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10,627 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,473
Recruiting: 1,285
Ph III recruiting: 130
Growth YoY: +6.4%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,641)

clinicaltrialsPublishedShowing 1–50 of 816 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07013435	A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship	recruiting	N/A	254	Massachusetts General HospitalOTHER	1	Sep 28, 2026	clinicaltrials
NCT07014293	Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors	recruiting	N/A	254	Massachusetts General HospitalOTHER	1	Sep 28, 2026	clinicaltrials